ARCHIVES

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

This article is from The Cancer Letter archive.

Vol. 22 No. 21 | May 24, 1996

Download PDF Visit The Full Archive

Related Articles

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review.

March 23, 2001

Evidence Lacking On Value of Vitamins to Prevent Disease, Panel Says.

June 16, 2006

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

NEJM Paper: Ownership of IMRT Centers Prompts Urologists to Refer Patients to Radiation Therapy

October 25, 2013

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013